Luteal Phase Defects: Diagnosis and Implications

Hilgers TW

doi:10.1016/b978-008055232-3.60950-x

Luteal Phase Defects: Diagnosis and Implications

Valarie Montgomery Rice, Paul F. Terranova, Thomas W Hilgers

University of Kansas Medical Center ROR
Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR

xPharm: The Comprehensive Pharmacology Reference, 1-3

DOI 10.1016/b978-008055232-3.60950-x

Abstract

No abstract available for this article.

Topics

Reproductive Endocrinology > Luteal Phase Deficiency > Diagnosis NaProTECHNOLOGY > Hormonal Assessment > Luteal Phase Evaluation Infertility > Hormonal Causes > Progesterone Insufficiency

luteal phase defect diagnosis progesterone insufficiency, Hilgers luteal phase deficiency NaProTECHNOLOGY, luteal phase defect infertility treatment implications, progesterone deficiency luteal phase diagnosis criteria, short luteal phase endometrial biopsy diagnosis, luteal phase inadequacy reproductive endocrinology, Hilgers luteal defect clinical implications fertility, corpus luteum insufficiency diagnosis hormonal assessment, progesterone support luteal phase defect management, luteal phase length ovulation progesterone deficiency

DOI 10.1016/b978-008055232-3.60950-x 10.1016/b978-008055232-3.60950-x

Cite this article

Hilgers, T. W. (1972). Luteal Phase Defects: Diagnosis and Implications. *xPharm: The Comprehensive Pharmacology Reference*, 1-3. https://doi.org/10.1016/b978-008055232-3.60950-x